Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of novel aporphine alkaloid derivative as potent TLR2 antagonist reversing macrophage polarization and neutrophil infiltration against acute inflammation. | Acta Pharm Sin B | 2023 | 37719381 | PubTator, text mining | PubMed |
| Narrative review of systemic inflammatory response mechanisms in cardiac surgery and immunomodulatory role of anesthetic agents. | Ann Card Anaesth | 2023 | 37706376 | PubTator, text mining | PubMed |
| The Science to Spirituality in Paediatric Palliative Care: A Commentary. | Indian J Palliat Care | 2023 | 37700902 | PubTator, text mining | PubMed |
| The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope? | Mol Ther Oncolytics | 2023 | 37680255 | PubTator, text mining | PubMed |
| Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence? | Ann Transl Med | 2023 | 37675296 | PubTator, text mining | PubMed |
| Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. | J Inflamm Res | 2023 | 37663754 | PubTator, text mining | PubMed |
| Cell-targeted vaccines: implications for adaptive immunity. | Front Immunol | 2023 | 37662903 | PubTator, text mining | PubMed |
| Drawing Parallels between SARS, MERS, and COVID-19: A Comparative Overview of Epidemiology, Pathogenesis, and Pathological Features. | Indian J Community Med | 2023 | 37662119 | PubTator, text mining | PubMed |
| Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity. | Virus Res | 2023 | 37657511 | PubTator, text mining | PubMed |
| Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies. | Acta Pharm Sin B | 2023 | 37655334 | PubTator, text mining | PubMed |
| Early Events after Herpes Simplex Virus-Type 1 Entry Are Necessary for the Release of Gamma-Hydroxybutyrate upon Acute Infection. | Pharmaceuticals (Basel) | 2023 | 37631019 | PubTator, text mining | PubMed |
| Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune Mice. | Cancers (Basel) | 2023 | 37627072 | PubTator, text mining | PubMed |
| The microbiome landscape in pediatric Crohn's disease and therapeutic implications. | Gut Microbes | 2023 | 37614093 | PubTator, text mining | PubMed |
| TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. | Nat Commun | 2023 | 37596248 | PubTator, text mining | PubMed |
| [Research progress on the role of respiratory microbiome in ventilator-associated pneumonia]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2023 | 37593873 | PubTator, text mining | PubMed |
| Characterizing metals in particulate pollution in communities at the fenceline of heavy industry: combining mobile monitoring and size-resolved filter measurements. | Environ Sci Process Impacts | 2023 | 37584085 | PubTator, text mining | PubMed |
| ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37580950 | PubTator, text mining | PubMed |
| Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation. | ACS Omega | 2023 | 37576639 | PubTator, text mining | PubMed |
| Integrative single-cell analysis of cardiac and pulmonary sarcoidosis using publicly available cardiac and bronchoalveolar lavage fluid sequencing datasets. | Front Cardiovasc Med | 2023 | 37576111 | PubTator, text mining | PubMed |
| scDual-Seq of Toxoplasma gondii-infected mouse BMDCs reveals heterogeneity and differential infection dynamics. | Front Immunol | 2023 | 37575232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=17